» Articles » PMID: 38494567

Single Center Experience with ALPPS and Timing with Stage 2 in Patients with Fibrotic/cirrhotic Liver

Overview
Journal Updates Surg
Specialty General Surgery
Date 2024 Mar 18
PMID 38494567
Authors
Affiliations
Soon will be listed here.
Abstract

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a novel procedure for major resection in patients with insufficient future liver remnant (FLR). Effective FLR augmentation is pivotal in the completion of ALPPS. Liver fibrosis/cirrhosis associated with chronic viral hepatitis impairs liver regeneration. To investigate the augmentation of FLR in associating ALPPS between patients with fibrotic/cirrhotic livers (FL) and non-fibrotic livers (NFL) and compare their short-term clinical outcomes and long-term survival. Patients were divided into two groups based on the Ishak modified staging: non-fibrotic liver group (NFL, stage 0) and fibrotic/cirrhotic liver group (FL, stage 1-5/6). Weekly liver regeneration in FLR, perioperative data, and survival outcomes were investigated. Twenty-seven patients with liver tumors underwent ALPPS (NFL, n = 7; FL, n = 20). NFL and FL patients had viral hepatitis (28.6% [n = 2] and 95% [n = 19]), absolute FLR volume increments of 134.90 ml and 161.85 ml (p = 0.825), and rates of hypertrophy were 16.46 ml/day and 13.66 ml/day (p = 0.507), respectively. In the FL group, baseline FLR volume was 360.13 ml, postoperatively it increased to a plateau (542.30 ml) in week 2 and declined (378.45 ml) in week 3. One patient (3.7%) with cirrhotic liver (stage 6) failed to proceed to ALPPS-II. The overall ALPPS-related major complication rate was 7.4%. ALPPS is feasible for fibrotic liver patients classified by Ishak modified stages ≤ 5. After ALPPS-I, 14 days for FLR augmentation seems an appropriate waiting time to reach a maximum FLR volume in these patients.

References
1.
Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S . Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999; 29(4):1099-105. DOI: 10.1002/hep.510290415. View

2.
Chan A, Chok K, Dai J, Lo C . Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS. Surgery. 2016; 161(2):357-364. DOI: 10.1016/j.surg.2016.07.029. View

3.
ISHAK K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F . Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22(6):696-9. DOI: 10.1016/0168-8278(95)80226-6. View

4.
Wang C, Jawade K, Yap A, Concejero A, Lin C, Chen C . Resection of large hepatocellular carcinoma using the combination of liver hanging maneuver and anterior approach. World J Surg. 2010; 34(8):1874-8. DOI: 10.1007/s00268-010-0546-9. View

5.
Abdalla E, Adam R, Bilchik A, Jaeck D, Vauthey J, Mahvi D . Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006; 13(10):1271-80. DOI: 10.1245/s10434-006-9045-5. View